ECHA reports on the progress made in 2023 in dossier and substance evaluation in line with Article 54 of REACH. 

During 2023, progress was made on 49 substances. 

The evaluating Member States assessed 4 new substances. Of these, the authorities considered that 2 required further information to clarify concerns, i.e. a draft decision requesting further information was sent to the registrants, whereas 2 had sufficient information to clarify the concerns, i.e. a draft conclusion was submitted by the authorities.

ECHA adopted 6 substance evaluation decisions, with 10 requests for further information to assess the safety of substances of potential concern.

The evaluating Member States completed their follow-up evaluations for 13 substances. For 4 substances, the evaluating Member State competent authority requested more information as the submitted information did not clarify the original concerns, or raised further concerns. For the remaining 9 substances, authorities found the available information to be sufficient to clarify the concerns and were able to conclude on whether there was a need for further regulatory action.

Substance evaluation was completed for 26 substances, i.e. conclusion documents from the evaluating Member States were published on our website. Of these 26 concluded cases, the authorities recommended further risk management measures for 19 substances, whereas 7 already had the necessary measures in place (or did not need any).